Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade.

Galanina N, Goodman AM, Cohen PR, Frampton GM, Kurzrock R.

Cancer Immunol Res. 2018 Sep 7. doi: 10.1158/2326-6066.CIR-18-0121. [Epub ahead of print]

PMID:
30194084
2.

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma.

Lee J, Zhang LL, Wu W, Guo H, Li Y, Sukhanova M, Venkataraman G, Zhang H, Alikhan M, Lu P, Guo A, Galanina N, Andrade J, Wang ML, Wang YL.

Blood Adv. 2018 Aug 28;2(16):2039-2051. doi: 10.1182/bloodadvances.2018016048.

3.

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.

Kadri S, Lee J, Fitzpatrick C, Galanina N, Sukhanova M, Venkataraman G, Sharma S, Long B, Petras K, Theissen M, Ming M, Kobzev Y, Kang W, Guo A, Wang W, Niu N, Weiner H, Thirman M, Stock W, Smith SM, Nabhan C, Segal JP, Lu P, Wang YL.

Blood Adv. 2017 May 2;1(12):715-727. doi: 10.1182/bloodadvances.2016003632. eCollection 2017 May 9.

4.

Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab.

Malecek MK, Petrich AM, Rozell S, Chu B, Trifilio S, Galanina N, Maurer M, Farooq U, Link BK, Nowakowski GS, Nabhan C, Ayed AO.

Am J Hematol. 2017 Nov;92(11):1156-1162. doi: 10.1002/ajh.24864. Epub 2017 Aug 17.

PMID:
28719025
5.

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.

Galanina N, Smith SM, Liao C, Petrich A, Libao B, Gartenhaus R, Westin JR, Cohen KS, Knost JA, Stadler WM, Doyle A, Karrison T, Gordon LI, Evens AM.

Br J Haematol. 2018 Apr;181(2):264-267. doi: 10.1111/bjh.14544. Epub 2017 Apr 17. No abstract available.

6.

Emerging role of checkpoint blockade therapy in lymphoma.

Galanina N, Kline J, Bishop MR.

Ther Adv Hematol. 2017 Feb;8(2):81-90. doi: 10.1177/2040620716673787. Epub 2017 Jan 22. Review.

7.

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.

Sharma S, Galanina N, Guo A, Lee J, Kadri S, Van Slambrouck C, Long B, Wang W, Ming M, Furtado LV, Segal JP, Stock W, Venkataraman G, Tang WJ, Lu P, Wang YL.

Oncotarget. 2016 Oct 18;7(42):68833-68841. doi: 10.18632/oncotarget.11932.

8.

Ofatumumab monotherapy in relapsed/refractory diffuse large B-cell non-Hodgkin lymphoma.

Galanina N, Jasielec J, Peace D, Smith SM, Nabhan C.

Leuk Lymphoma. 2017 Mar;58(3):752-753. doi: 10.1080/10428194.2016.1207764. Epub 2016 Jul 14. No abstract available.

PMID:
27415580
9.

Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia.

Nabhan C, Chaffee KG, Slager SL, Galanina N, Achenbach SJ, Schwager SM, Kay NE, Shanafelt TD.

Am J Hematol. 2016 Jul;91(7):677-80. doi: 10.1002/ajh.24374. Epub 2016 Apr 24.

10.

The evolving role of lenalidomide in non-Hodgkin lymphoma.

Galanina N, Petrich A, Nabhan C.

Leuk Lymphoma. 2016 Jul;57(7):1507-16. doi: 10.3109/10428194.2016.1146949. Epub 2016 Feb 22. Review.

PMID:
26902680
11.

Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib.

Guo A, Lu P, Galanina N, Nabhan C, Smith SM, Coleman M, Wang YL.

Oncotarget. 2016 Jan 26;7(4):4598-610. doi: 10.18632/oncotarget.6727.

12.

Molecular predictors of response to therapy for breast cancer.

Galanina N, Bossuyt V, Harris LN.

Cancer J. 2011 Mar-Apr;17(2):96-103. doi: 10.1097/PPO.0b013e318212dee3. Review.

PMID:
21427553
13.

Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy.

Saif MW, Galanina N, Ravage-Mass L, Kaley K, Cornfeld D, Lamb L, Chhieng D.

Case Rep Med. 2010;2010. pii: 634975. doi: 10.1155/2010/634975. Epub 2010 Aug 24.

14.

Blood glucose levels before and after cognitive testing in diabetes mellitus.

Galanina N, Surampudi V, Ciltea D, Singh SP, Perlmuter LC.

Exp Aging Res. 2008 Apr-Jun;34(2):152-61. doi: 10.1080/03610730701876979.

PMID:
18351501
15.

[The role of interventricular septum in kinetics of left and right ventricular contraction in patients with ischemic heart disease and chronic cardiac failure].

Fomina IG, Georgadze ZO, Galanina NA, Gaĭdamakina NE, Kiniasheva NB.

Ter Arkh. 2006;78(12):19-24. Russian.

PMID:
17294858
16.

[Local myocardial contractility in patients with coronary heart disease and chronic heart failure].

Fomina IG, Galanina NA, Matveev VV, Gaĭdamakina NE, Sinitsyna MG, Anastasian GA.

Klin Med (Mosk). 2006;84(2):35-9. Russian.

PMID:
16613004
17.

[Diagnosis of the hibernating myocardium in early stages of heart failure in patients with coronary heart disease].

Fomina IG, Georgadze ZA, Gaĭdamakina NE, Galanina NA.

Klin Med (Mosk). 2000;78(4):24-7. Russian.

PMID:
10833885
18.

[Electromechanical drive for a perfusion pump].

Khakhan IuV, Barbarash BI, Galanina NN, Popova EIa, Rogoza AN.

Med Tekh. 1976 Nov-Dec;(6):19-21. Russian. No abstract available.

PMID:
1027980

Supplemental Content

Loading ...
Support Center